世界の胃がん検査・治療・予防市場2021:メーカー別・地域別・種類別・用途別市場予測(~2026)

GlobalInfoResearchが発行した調査報告書(GIR21JY00001)
◆英語タイトル:Global Gastric Cancer Testing, Treatment and Prevention Market 2021 by Company, Regions, Type and Application, Forecast to 2026
◆商品コード:GIR21JY00001
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2021年7月(※2024年版があります。お問い合わせください。)
◆ページ数:100
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2~3日)
◆調査対象地域:グローバル
◆産業分野:産業機械&装置
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

GlobalInfoResearch社の本調査レポートでは、胃がん検査・治療・予防の世界市場を広く調査・分析し、今後の市場展望をまとめております。胃がん検査・治療・予防の種類別市場規模(検査、治療、予防)、用途別市場規模(病院、クリニック、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(企業概要、製品概要、販売量、価格、売上):Biogen Idec、Bristol Myers Squibb、Eli Lilly And Company、Glaxosmithkline Genentech, Inc、Hoffmann-La Roche Inc.、Immunogen Merck & Company、Novartis、Pacific Edge Diagnostics Nz、Pfizer、Roche/Genentech Oncolytics、Zova Biotherapeutics Inc.
・メーカー別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:検査、治療、予防
・用途別分析2016年-2026年:病院、クリニック、その他
・胃がん検査・治療・予防の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・胃がん検査・治療・予防のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・胃がん検査・治療・予防のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・胃がん検査・治療・予防の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・胃がん検査・治療・予防の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
【レポートの概要】

The Gastric Cancer Testing, Treatment and Prevention market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Gastric Cancer Testing, Treatment and Prevention size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Gastric Cancer Testing, Treatment and Prevention market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Gastric Cancer Testing, Treatment and Prevention market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Test
Treatment
Prevention

Market segment by Application, can be divided into
Hospitals
Clinics
Other

Market segment by players, this report covers
Biogen Idec
Bristol Myers Squibb
Eli Lilly And Company
Glaxosmithkline Genentech, Inc
Hoffmann-La Roche Inc.
Immunogen Merck & Company
Novartis
Pacific Edge Diagnostics Nz
Pfizer
Roche/Genentech Oncolytics
Zova Biotherapeutics Inc.

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

【レポートの目次】

1 Market Overview
1.1 Product Overview and Scope of Gastric Cancer Testing, Treatment and Prevention
1.2 Classification of Gastric Cancer Testing, Treatment and Prevention by Type
1.2.1 Overview: Global Gastric Cancer Testing, Treatment and Prevention Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Type in 2020
1.2.3 Test
1.2.4 Treatment
1.2.5 Prevention
1.3 Global Gastric Cancer Testing, Treatment and Prevention Market by Application
1.3.1 Overview: Global Gastric Cancer Testing, Treatment and Prevention Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Gastric Cancer Testing, Treatment and Prevention Market Size & Forecast
1.5 Global Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast by Region
1.5.1 Global Gastric Cancer Testing, Treatment and Prevention Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Gastric Cancer Testing, Treatment and Prevention Market Size by Region, (2016-2021)
1.5.3 North America Gastric Cancer Testing, Treatment and Prevention Market Size and Prospect (2016-2026)
1.5.4 Europe Gastric Cancer Testing, Treatment and Prevention Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Market Size and Prospect (2016-2026)
1.5.6 South America Gastric Cancer Testing, Treatment and Prevention Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Gastric Cancer Testing, Treatment and Prevention Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Gastric Cancer Testing, Treatment and Prevention Market Drivers
1.6.2 Gastric Cancer Testing, Treatment and Prevention Market Restraints
1.6.3 Gastric Cancer Testing, Treatment and Prevention Trends Analysis
2 Company Profiles
2.1 Biogen Idec
2.1.1 Biogen Idec Details
2.1.2 Biogen Idec Major Business
2.1.3 Biogen Idec Gastric Cancer Testing, Treatment and Prevention Product and Solutions
2.1.4 Biogen Idec Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Biogen Idec Recent Developments and Future Plans
2.2 Bristol Myers Squibb
2.2.1 Bristol Myers Squibb Details
2.2.2 Bristol Myers Squibb Major Business
2.2.3 Bristol Myers Squibb Gastric Cancer Testing, Treatment and Prevention Product and Solutions
2.2.4 Bristol Myers Squibb Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Bristol Myers Squibb Recent Developments and Future Plans
2.3 Eli Lilly And Company
2.3.1 Eli Lilly And Company Details
2.3.2 Eli Lilly And Company Major Business
2.3.3 Eli Lilly And Company Gastric Cancer Testing, Treatment and Prevention Product and Solutions
2.3.4 Eli Lilly And Company Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Eli Lilly And Company Recent Developments and Future Plans
2.4 Glaxosmithkline Genentech, Inc
2.4.1 Glaxosmithkline Genentech, Inc Details
2.4.2 Glaxosmithkline Genentech, Inc Major Business
2.4.3 Glaxosmithkline Genentech, Inc Gastric Cancer Testing, Treatment and Prevention Product and Solutions
2.4.4 Glaxosmithkline Genentech, Inc Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Glaxosmithkline Genentech, Inc Recent Developments and Future Plans
2.5 Hoffmann-La Roche Inc.
2.5.1 Hoffmann-La Roche Inc. Details
2.5.2 Hoffmann-La Roche Inc. Major Business
2.5.3 Hoffmann-La Roche Inc. Gastric Cancer Testing, Treatment and Prevention Product and Solutions
2.5.4 Hoffmann-La Roche Inc. Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Hoffmann-La Roche Inc. Recent Developments and Future Plans
2.6 Immunogen Merck & Company
2.6.1 Immunogen Merck & Company Details
2.6.2 Immunogen Merck & Company Major Business
2.6.3 Immunogen Merck & Company Gastric Cancer Testing, Treatment and Prevention Product and Solutions
2.6.4 Immunogen Merck & Company Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Immunogen Merck & Company Recent Developments and Future Plans
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business
2.7.3 Novartis Gastric Cancer Testing, Treatment and Prevention Product and Solutions
2.7.4 Novartis Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Novartis Recent Developments and Future Plans
2.8 Pacific Edge Diagnostics Nz
2.8.1 Pacific Edge Diagnostics Nz Details
2.8.2 Pacific Edge Diagnostics Nz Major Business
2.8.3 Pacific Edge Diagnostics Nz Gastric Cancer Testing, Treatment and Prevention Product and Solutions
2.8.4 Pacific Edge Diagnostics Nz Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Pacific Edge Diagnostics Nz Recent Developments and Future Plans
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business
2.9.3 Pfizer Gastric Cancer Testing, Treatment and Prevention Product and Solutions
2.9.4 Pfizer Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Pfizer Recent Developments and Future Plans
2.10 Roche/Genentech Oncolytics
2.10.1 Roche/Genentech Oncolytics Details
2.10.2 Roche/Genentech Oncolytics Major Business
2.10.3 Roche/Genentech Oncolytics Gastric Cancer Testing, Treatment and Prevention Product and Solutions
2.10.4 Roche/Genentech Oncolytics Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Roche/Genentech Oncolytics Recent Developments and Future Plans
2.11 Zova Biotherapeutics Inc.
2.11.1 Zova Biotherapeutics Inc. Details
2.11.2 Zova Biotherapeutics Inc. Major Business
2.11.3 Zova Biotherapeutics Inc. Gastric Cancer Testing, Treatment and Prevention Product and Solutions
2.11.4 Zova Biotherapeutics Inc. Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Zova Biotherapeutics Inc. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Gastric Cancer Testing, Treatment and Prevention Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Gastric Cancer Testing, Treatment and Prevention Players Market Share
3.2.2 Top 10 Gastric Cancer Testing, Treatment and Prevention Players Market Share
3.2.3 Market Competition Trend
3.3 Gastric Cancer Testing, Treatment and Prevention Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Gastric Cancer Testing, Treatment and Prevention Revenue and Market Share by Type (2016-2021)
4.2 Global Gastric Cancer Testing, Treatment and Prevention Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Application (2016-2021)
5.2 Gastric Cancer Testing, Treatment and Prevention Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Gastric Cancer Testing, Treatment and Prevention Revenue by Type (2016-2026)
6.2 North America Gastric Cancer Testing, Treatment and Prevention Revenue by Application (2016-2026)
6.3 North America Gastric Cancer Testing, Treatment and Prevention Market Size by Country
6.3.1 North America Gastric Cancer Testing, Treatment and Prevention Revenue by Country (2016-2026)
6.3.2 United States Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
6.3.3 Canada Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
6.3.4 Mexico Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Gastric Cancer Testing, Treatment and Prevention Revenue by Type (2016-2026)
7.2 Europe Gastric Cancer Testing, Treatment and Prevention Revenue by Application (2016-2026)
7.3 Europe Gastric Cancer Testing, Treatment and Prevention Market Size by Country
7.3.1 Europe Gastric Cancer Testing, Treatment and Prevention Revenue by Country (2016-2026)
7.3.2 Germany Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
7.3.3 France Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
7.3.5 Russia Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
7.3.6 Italy Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Revenue by Type (2016-2026)
8.2 Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Revenue by Application (2016-2026)
8.3 Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Market Size by Region
8.3.1 Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Revenue by Region (2016-2026)
8.3.2 China Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
8.3.3 Japan Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
8.3.4 South Korea Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
8.3.5 India Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
8.3.7 Australia Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Gastric Cancer Testing, Treatment and Prevention Revenue by Type (2016-2026)
9.2 South America Gastric Cancer Testing, Treatment and Prevention Revenue by Application (2016-2026)
9.3 South America Gastric Cancer Testing, Treatment and Prevention Market Size by Country
9.3.1 South America Gastric Cancer Testing, Treatment and Prevention Revenue by Country (2016-2026)
9.3.2 Brazil Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
9.3.3 Argentina Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Gastric Cancer Testing, Treatment and Prevention Revenue by Type (2016-2026)
10.2 Middle East & Africa Gastric Cancer Testing, Treatment and Prevention Revenue by Application (2016-2026)
10.3 Middle East & Africa Gastric Cancer Testing, Treatment and Prevention Market Size by Country
10.3.1 Middle East & Africa Gastric Cancer Testing, Treatment and Prevention Revenue by Country (2016-2026)
10.3.2 Turkey Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
10.3.4 UAE Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

...

【掲載企業】

Biogen Idec、Bristol Myers Squibb、Eli Lilly And Company、Glaxosmithkline Genentech, Inc、Hoffmann-La Roche Inc.、Immunogen Merck & Company、Novartis、Pacific Edge Diagnostics Nz、Pfizer、Roche/Genentech Oncolytics、Zova Biotherapeutics Inc.

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の胃がん検査・治療・予防市場2021:メーカー別・地域別・種類別・用途別市場予測(~2026)(Global Gastric Cancer Testing, Treatment and Prevention Market 2021 by Company, Regions, Type and Application, Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。